STOCK TITAN

Insider Howard Horn plans share sale in RARE (RARE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Howard Horn filed a notice to sell 3,061 common shares through Morgan Stanley Smith Barney, with an aggregate market value of 72,117.16. The shares relate to restricted stock acquired from the issuer on 10/09/2024 and 10/09/2025. The planned sale is expected around 02/02/2026 on the NASDAQ, where 96,477,569 shares of this class were outstanding. In the prior three months, Howard Horn sold 3,081 shares for gross proceeds of 112,086.78 and 3,150 shares for 71,946.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for RARE disclose about Howard Horn?

The notice shows Howard Horn plans to sell 3,061 common shares through Morgan Stanley Smith Barney. It also lists earlier three-month sales totaling 6,231 shares, with gross proceeds of 112,086.78 and 71,946.00 from two separate transactions.

How many RARE shares does Howard Horn currently plan to sell under this Form 144?

The filing covers a proposed sale of 3,061 common shares. These shares will be sold through Morgan Stanley Smith Barney, Executive Financial Services, with an aggregate market value of 72,117.16 based on the market data referenced in the notice.

When is Howard Horn’s planned RARE share sale expected to occur?

The approximate sale date stated is 02/02/2026. The filing identifies the NASDAQ as the securities exchange where the common shares are expected to be sold, using Morgan Stanley Smith Barney as the executing broker.

What were Howard Horn’s recent RARE share sales before this Form 144 notice?

In the past three months, he sold 3,081 common shares on 12/10/2025 for gross proceeds of 112,086.78, and 3,150 common shares on 01/02/2026 for gross proceeds of 71,946.00, according to the disclosure table.

How were the RARE shares in Howard Horn’s planned Form 144 sale originally acquired?

The shares relate to restricted stock acquired directly from the issuer. The filing lists 1,744 shares acquired on 10/09/2024 and 1,317 shares acquired on 10/09/2025, both identified as restricted stock transactions with payment described as not applicable.

How many RARE common shares are outstanding according to this Form 144?

The notice states that 96,477,569 common shares were outstanding. This figure provides context for the relative size of the planned 3,061-share sale compared with the total number of shares of this class in the market.
Ultragenyx Pharm

NASDAQ:RARE

RARE Rankings

RARE Latest News

RARE Latest SEC Filings

RARE Stock Data

2.30B
92.14M
3.14%
101.49%
8.63%
Biotechnology
Pharmaceutical Preparations
Link
United States
NOVATO